These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 3816947)
21. Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand. Zehender H; Witte EC; Wolff HP; Patscheke H Biochem Pharmacol; 1988 Feb; 37(3):491-5. PubMed ID: 2962585 [TBL] [Abstract][Full Text] [Related]
22. Characterization of U46619 binding in unactivated, intact human platelets and determination of binding site affinities of four TXA2/PGH2 receptor antagonists (13-APA, BM 13.177, ONO 3708 and SQ 29,548). Kattelman EJ; Venton DL; Le Breton GC Thromb Res; 1986 Feb; 41(4):471-81. PubMed ID: 3008368 [TBL] [Abstract][Full Text] [Related]
23. Photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor. Mais DE; Yoakim C; Guindon Y; Gillard JW; Rokach J; Halushka PV Biochim Biophys Acta; 1989 Jul; 1012(2):184-90. PubMed ID: 2525928 [TBL] [Abstract][Full Text] [Related]
29. pH-dependent binding of the TXA2/PGH2-receptor of human platelet membranes to various ligands. Theis JG; Dellweg H; Perzborn E; Gross R Agents Actions Suppl; 1992; 37():222-7. PubMed ID: 1385924 [TBL] [Abstract][Full Text] [Related]
30. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145. Hanasaki K; Nagasaki T; Arita H Biochem Pharmacol; 1989 Jun; 38(12):2007-17. PubMed ID: 2525906 [TBL] [Abstract][Full Text] [Related]
31. Binding of an [125I] labelled thromboxane A2/prostaglandin H2 receptor agonist to baboon platelets. Dorn GW; De Jesus A Prostaglandins; 1989 Dec; 38(6):645-53. PubMed ID: 2534431 [TBL] [Abstract][Full Text] [Related]
32. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat. Masuda A; Mais DE; Oatis JE; Halushka PV Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482 [TBL] [Abstract][Full Text] [Related]
34. Solubilization of a thromboxane A2/prostaglandin H2 antagonist binding site from human platelets. Burch RM; Mais DE; Saussy DL; Halushka PV Proc Natl Acad Sci U S A; 1985 Nov; 82(21):7434-8. PubMed ID: 2997791 [TBL] [Abstract][Full Text] [Related]
35. Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptor. Mayeux PR; Mais DE; Halushka PV Eur J Pharmacol; 1991 Jan; 206(1):15-21. PubMed ID: 1712307 [TBL] [Abstract][Full Text] [Related]
36. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets. Yin K; Halushka PV; Yan YT; Wong PY J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171 [TBL] [Abstract][Full Text] [Related]
38. A comparative study of the involvement of the prostaglandin H2/thromboxane A2 pathway in intravascular platelet aggregation in guinea-pigs and rats. Mallarkey G; Smith GM Br J Pharmacol; 1985 Feb; 84(2):425-30. PubMed ID: 3156648 [TBL] [Abstract][Full Text] [Related]
39. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP. Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565 [No Abstract] [Full Text] [Related]